Newsroom

SHANGHÁI, China, y JERSEY CITY, Nueva Jersey--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) y Organon (NYSE: OGN) han anunciado hoy que la Comisión Europea (CE) ha concedido la autorización de comercialización de POHERDY®(pertuzumab), una solución inyectable intravenosa de 420 mg/14 ml, el primer y único biosimilar de PERJETA (pertuzumab) aprobado en Europa, para todas las indicaciones del medicamento de referencia.1 «Al ser el primer biosimilar de pertuzumab, y actualmente el único...

SANTA CLARA, Calif. & STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Yubico (NASDAQ STOCKHOLM: YUBICO), the pioneer of phishing-resistant authentication and creator of the YubiKey, the gold standard of security keys, today announced an industry-first collaboration with OpenAI, the creator of ChatGPT. Beginning today, people can purchase a new 2-pack set of custom YubiKeys as part of OpenAI’s Advanced Account Security program – enabling them to secure their ChatGPT accounts with security keys, con...

SANTA CLARA, Kalifornien och STOCKHOLM, Sverige--(BUSINESS WIRE)--Regulatory News: Yubico (NASDAQ STOCKHOLM: YUBICO), pionjär inom nätfiskeresistent autentisering och skaparen av YubiKey, guldstandarden för säkerhetsnycklar, meddelar idag ett branschledande samarbete med OpenAI, skaparen av ChatGPT. Från och med idag kan OpenAI:s användare köpa ett tvåpack med specialdesignade YubiKeys inom ramen för OpenAI:s program för avancerad kontosäkerhet (Advanced Account Security program). Det gör det m...

SHANGHAI, Cina e JERSEY CITY, N.J.--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK), e Organon (NYSE: OGN) oggi hanno annunciato che la Commissione Europea (CE) ha concesso l'autorizzazione all'immissione in commercio per POHERDY® (pertuzumab) 420 mg/14 mL iniezione per uso endovenoso, il primo e unico biosimilare di PERJETA (pertuzumab) approvato in Europa, per tutte le indicazioni del prodotto di riferimento.1 “In quanto primo e attualmente unico biosimilare del pertuzumab in Europe...

SHANGHAI, China, und JERSEY CITY, New Jersey, USA--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Kommission die Zulassung für POHERDY® (Pertuzumab) 420 mg/14 ml Injektion zur intravenösen Verabreichung erteilt hat. Damit ist POHERDY das erste und einzige in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) für alle Indikationen des Referenzprodukts.1 „Als erstes und derzeit einziges Pertuzumab-Biosimilar in Europa...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Northfield Bancorp, Inc. (NasdaqGS: NFBK) and Columbia Financial, Inc. (NasdaqGS: CLBK). Under the terms of the proposed transaction, each Northfield share will be converted into either stock or cash, at the holder’s election, with consideration tied to the final independent valuation: from 1.425–1.465 holdi...

SANTA CLARA, Kalifornien, und STOCKHOLM, Schweden--(BUSINESS WIRE)--Yubico (NASDAQ STOCKHOLM: YUBICO), der Pionier der Phishing-resistenten Authentifizierung und Entwickler des YubiKey, dem Goldstandard unter den Sicherheitsschlüsseln, gab heute eine branchenweit einzigartige Zusammenarbeit mit OpenAI, dem Entwickler von ChatGPT, bekannt. Ab heute können Nutzer im Rahmen des „Advanced Account Security“-Programms von OpenAI ein neues 2er-Set maßgeschneiderter YubiKeys erwerben, mit denen sie ihr...

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Thermon Group Holdings, Inc. (NYSE: THR) to CECO Environmental Corp. (NasdaqGS: CECO). Under the terms of the proposed transaction, shareholders of Thermon may elect to receive, for each share of Thermon common stock, either: (i) $10.00 in cash and 0.6840 shares of CECO common stock, (ii) $63.8...

FRANKFORT, Ky.--(BUSINESS WIRE)--Investors Heritage Life Insurance Company (“Investors Heritage”) is pleased to announce that Anna Reynolds was promoted to Senior Vice President and General Counsel effective 2025. Ms. Reynolds joined Investors Heritage in 2017 and has previously served as Associate General Counsel and Assistant Vice President. Since joining the company, she has provided strategic legal and regulatory guidance across all aspects of the business, supporting the company’s long-ter...

SANTA CLARA, Californie et STOCKHOLM, Suède--(BUSINESS WIRE)--Yubico (NASDAQ STOCKHOLM : YUBICO), pionnier de l'authentification résistante au phishing et créateur de la YubiKey, la référence en matière de clés de sécurité, annonce une collaboration inédite dans le secteur avec OpenAI, le créateur de ChatGPT. Dèsaujourd’hui, les utilisateurs peuvent acheter un nouveau pack de deux YubiKeys personnalisées dans le cadre du programme Advanced Account Security d’OpenAI, ce qui leur permet de sécuri...